24 studies found for:    Open Studies | "Encephalitis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
2 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:
3 Unknown  Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
4 Not yet recruiting Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis chimeric vaccine (JECV)
5 Not yet recruiting 6-year Antibody Check After Third Vaccination Against Japanese Encephalitis
Condition: Post Other Specified Vaccination Encephalitis
Intervention: Other: Blood draw
6 Recruiting The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans
Conditions: Yellow Fever;   Encephalitis, Japanese
Interventions: Biological: Japanese Encephalitis vaccine;   Biological: Yellow Fever vaccine
7 Unknown  Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
Condition: Tick-borne Encephalitis
Intervention: Biological: FSME-immune
8 Recruiting Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients
Condition: Tick Borne Encephalitis
Intervention: Biological: TBE virus vaccine
9 Recruiting Post-licensure Safety Study of IMOJEV® in Thailand
Condition: Japanese Encephalitis
Intervention: Biological: IMOJEV®: Live attenuated Japanese encephalitis chimeric virus vaccine
10 Recruiting Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis
Condition: Anti-NMDA Receptor Encephalitis
Interventions: Device: tDCS;   Device: Sham Stimulation
11 Unknown  Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR
Conditions: Malaria;   Dengue;   Japanese Encephalitis
Interventions: Drug: 20% deet insect repellent;   Drug: placebo control
12 Recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Condition: West Nile Virus
Interventions: Biological: WN/DEN4Δ30 Vaccine;   Biological: Placebo
13 Not yet recruiting B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study.
Condition: Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)
Interventions: Drug: Rituximab;   Drug: Placebo
14 Recruiting Brain Inflammation and Function in Alcoholism
Condition: Alcoholism
Interventions: Device: MRI;   Drug: C-11PBR28;   Drug: F-18FDG
15 Recruiting Brain Inflammation in Major Depressive Disorder Background
Condition: Major Depression
Intervention:
16 Recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide
17 Recruiting Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
18 Recruiting Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
19 Recruiting Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients
Conditions: Meningoencephalitis;   Other Syndromes Requiring Lumbar Puncture in Emergency Department
Intervention: Other: no intervention
20 Not yet recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
Indicates status has not been verified in more than two years